We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+4.06%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$39.7B
AUM Growth
+$3.58B
(+9.9%)
Cap. Flow
+$2.92B
Cap. Flow
% of AUM
7.34%
Top 10 Holdings %
Top 10 Hldgs %
15.27%
Holding
2,330
New
168
Increased
907
Reduced
894
Closed
217
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Williams Companies
WMB
|
+$260M |
| 2 |
Entergy
ETR
|
+$254M |
| 3 |
Philip Morris
PM
|
+$217M |
| 4 |
Pfizer
PFE
|
+$184M |
| 5 |
LyondellBasell Industries
LYB
|
+$179M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$404M |
| 2 |
Merck
MRK
|
+$328M |
| 3 |
Gilead Sciences
GILD
|
+$142M |
| 4 |
Clorox
CLX
|
+$121M |
| 5 |
Align Technology
ALGN
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.7% |
| 2 | Technology | 13.73% |
| 3 | Financials | 11.58% |
| 4 | Consumer Staples | 9.23% |
| 5 | Consumer Discretionary | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Bio-Rad Laboratories Class A
BIO
$9.87B
| $23.1M | 0.06% |
48,200
+10,661
| +28% | +$4.99M |
|
352
CRISPR Therapeutics
CRSP
$5.12B
| $23M | 0.06% |
508,758
| – | – |
|
353
Teradyne
TER
$51.5B
| $22.9M | 0.06% |
212,967
-9,922
| -4% | -$1.01M |
|
354
Boise Cascade
BCC
$2.63B
| $22.8M | 0.06% |
360,363
-27,463
| -7% | -$1.9M |
|
355
W.R. Berkley
WRB
$25.9B
| $22.8M | 0.06% |
548,378
-254,016
| -32% | -$11.4M |
|
356
American International
AIG
$39.4B
| $22.6M | 0.06% |
449,659
+19,836
| +5% | +$1.16M |
|
357
Intapp
INTA
$2.85B
| $22.5M | 0.06% |
+501,425
| New | +$17.6M |
|
358
Tenet Healthcare
THC
$21.2B
| $22.4M | 0.06% |
377,639
-46,128
| -11% | -$2.56M |
|
|
NOVA
359
DELISTED
Sunnova Energy
NOVA
| $22.4M | 0.06% |
1,434,487
+387,665
| +37% | +$6.77M |
|
|
DCBO
360
Docebo
DCBO
$605M
| $22.4M | 0.06% |
549,449
| – | – |
|
361
Telefônica Brasil
VIV
$19B
| $22.3M | 0.06% |
2,940,724
+644,216
| +28% | +$4.84M |
|
362
Johnson Controls International
JCI
$83.4B
| $22.1M | 0.06% |
366,680
-31,080
| -8% | -$1.99M |
|
|
FUSN
363
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $22.1M | 0.06% |
5,849,100
+2,625,000
| +81% | +$10.3M |
|
364
Live Oak Bancshares
LOB
$1.82B
| $22M | 0.06% |
904,130
-228,034
| -20% | -$7.15M |
|
365
Starbucks
SBUX
$113B
| $22M | 0.06% |
211,477
+150,751
| +248% | +$15.7M |
|
366
Natera
NTRA
$47.4B
| $22M | 0.06% |
396,101
+170,301
| +75% | +$8.17M |
|
367
TE Connectivity
TEL
$61.4B
| $22M | 0.06% |
167,466
+158,544
| +1,777% | +$20.1M |
|
368
AbCellera Biologics
ABCL
$3.62B
| $21.9M | 0.06% |
2,904,259
+381,937
| +15% | +$3.47M |
|
|
NSA
369
DELISTED
National Storage Affiliates Trust
NSA
| $21.7M | 0.05% |
519,555
-205,830
| -28% | -$8.33M |
|
370
Intercontinental Exchange
ICE
$88.4B
| $21.7M | 0.05% |
207,637
+204,577
| +6,686% | +$21.3M |
|
371
MYR Group
MYRG
$4.23B
| $21.4M | 0.05% |
170,085
+58,098
| +52% | +$6.25M |
|
372
Skyworks Solutions
SWKS
$13.3B
| $21.4M | 0.05% |
181,583
-60,912
| -25% | -$6.75M |
|
373
Brighthouse Financial
BHF
$2.88B
| $21.4M | 0.05% |
485,672
-3,149
| -0.6% | -$165K |
|
|
ATYR
374
aTyr Pharma
ATYR
$38.1M
| $21.4M | 0.05% |
10,189,966
+4,958,366
| +95% | +$10.9M |
|
375
A.O. Smith
AOS
$7.8B
| $21.2M | 0.05% |
306,420
+2,068
| +0.7% | +$134K |
|
Similar funds
Federated Hermes's Q1 2023 Portfolio in Review
As of Q1 2023, Federated Hermes held 2,330 positions worth $39.7B, up 9.9% from $36.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.92B of net new capital in Q1 2023, opening 168 new positions and adding to 907 existing holdings. Its largest new stake was Rogers Corp: 345,466 shares worth $56.5M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 23% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was JPMorgan Chase, an estimated $404M trimmed.
- Federated Hermes's largest Q1 2023 buy was Rogers Corp: 345,466 shares worth $56.5M.
- Federated Hermes added most to Williams Companies in Q1 2023, an estimated $260M increase.
- Federated Hermes's biggest Q1 2023 reduction was JPMorgan Chase, cutting an estimated $404M.
- Federated Hermes fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $56.3M.
- Federated Hermes's ten largest holdings make up 15% of its $39.7B portfolio in Q1 2023.
- Federated Hermes opened 168 new positions and closed 217 in Q1 2023.
- Federated Hermes's portfolio value rose 9.9% quarter-over-quarter to $39.7B.
Based on Federated Hermes's 13F filing for Q1 2023, filed 8 May 2023.